BioLife Solutions Quarterly Balance Sheets Chart
Quarterly
|
Annual
BioLife Solutions Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 66,945,000 | 95,386,000 | 23,977,000 | 22,014,000 | 29,694,000 | 35,407,000 | 19,235,000 | 21,400,000 | 19,105,000 | 19,442,000 | 27,036,000 | 24,001,000 | 59,463,000 | 69,860,000 | 75,098,000 | 76,246,000 | 89,012,000 | 90,403,000 | 93,984,000 | 29,879,000 | 6,400,000 | 6,448,000 | 21,205,000 | 19,617,000 | 31,824,000 | 30,657,000 | 32,380,674 | 14,166,604 | 7,032,513 | 6,663,318 | 2,830,541 | 2,314,633 | 2,289,926 | 1,405,826 | 1,368,583 | 1,318,469 | 1,662,431 | 2,173,258 | 2,351,540 | 3,896,405 | 2,971,840 | 2,538,758 | 3,275,057 | 5,902,228 | 12,839,600 | 156,273 | 79,287 | 76,205 | 61,523 | 196,478 | 7,529 | 155,354 | 70,524 | 16,864 | 20,117 | 36,145 | 35,097 | 3,211 | 298 | 67,881 | 2,292 | 139,151 | 95,814 | 86,403 | 428,196 | 85,070 | 87,715 | 136,182 |
available-for-sale securities, current portion | 21,635,000 | 9,198,000 | 10,211,000 | 12,120,000 | 15,579,000 | 16,288,000 | 21,794,000 | 24,858,000 | 35,780,000 | 43,260,000 | 34,583,000 | 22,546,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 117 and 153 as of march 31, 2025 and december 31, 2024, respectively | 9,167,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventories | 27,566,000 | 29,013,000 | 32,179,000 | 32,496,000 | 43,414,000 | 43,456,000 | 43,354,000 | 39,177,000 | 41,329,000 | 34,904,000 | 33,747,000 | 33,335,000 | 30,200,000 | 28,345,000 | 29,696,000 | 25,866,000 | 11,666,000 | 11,602,000 | 11,037,000 | 10,890,000 | 10,829,000 | 10,972,000 | 5,694,000 | 5,306,000 | 4,060,000 | 3,509,000 | 2,910,927 | 2,121,881 | 1,836,666 | 1,846,746 | 1,861,058 | 1,769,070 | 1,812,172 | 1,757,784 | 1,903,759 | 1,910,729 | 2,018,255 | 1,834,635 | 1,783,383 | 1,321,257 | 1,242,787 | 965,224 | 717,624 | 678,156 | 297,105 | 420,924 | 409,195 | 593,138 | 676,438 | 656,397 | 849,211 | 916,810 | 763,967 | 505,956 | 475,126 | 509,572 | 447,306 | 410,486 | 499,450 | 532,431 | 436,529 | 358,219 | 237,651 | 379,230 | 453,011 | 587,726 | 121,655 | 97,047 |
prepaid expenses and other current assets | 5,816,000 | 5,996,000 | 4,914,000 | 3,475,000 | 4,408,000 | 6,765,000 | 7,854,000 | 7,985,000 | 6,201,000 | 6,879,000 | 8,041,000 | 6,890,000 | 4,757,000 | 4,427,000 | 5,426,000 | 4,156,000 | 5,143,000 | 4,648,000 | 1,668,000 | 1,134,000 | 1,016,000 | 1,348,000 | 855,000 | 384,000 | 346,000 | 353,000 | 298,005 | 352,507 | 330,904 | 399,502 | 320,318 | 422,408 | 419,124 | 270,814 | 381,883 | 402,342 | 435,592 | 384,414 | 453,789 | 313,412 | 289,018 | 360,521 | 320,761 | 312,148 | 202,784 | 291,745 | 140,077 | 165,292 | 201,801 | 174,731 | 122,914 | 76,657 | 68,299 | 90,444 | 90,903 | 66,530 | 77,782 | 62,377 | 69,837 | 73,267 | 85,747 | 79,635 | 138,814 | 44,655 | 123,816 | |||
total current assets | 131,129,000 | 148,761,000 | 89,383,000 | 88,200,000 | 111,700,000 | 120,604,000 | 116,824,000 | 120,311,000 | 132,789,000 | 138,452,000 | 135,874,000 | 118,057,000 | 118,701,000 | 125,859,000 | 130,505,000 | 127,414,000 | 116,543,000 | 114,712,000 | 127,784,000 | 46,254,000 | 26,450,000 | 24,113,000 | 32,067,000 | 29,139,000 | 39,157,000 | 37,564,000 | 38,288,948 | 18,807,407 | 10,243,898 | 9,930,881 | 6,367,032 | 5,679,147 | 5,581,995 | 4,628,070 | 4,965,231 | 4,915,555 | 5,306,538 | 6,972,937 | 8,283,091 | 9,296,889 | 10,961,142 | 12,165,762 | 12,832,803 | 13,471,381 | 14,665,053 | 1,878,258 | 1,655,417 | 1,815,609 | 1,915,919 | 1,627,759 | 1,777,597 | 1,508,011 | 1,374,606 | 1,160,407 | 1,044,823 | 1,007,571 | 916,886 | 814,973 | 886,643 | 958,820 | 883,340 | 892,370 | 841,608 | 709,480 | 1,329,890 | 1,168,198 | 744,908 | 743,048 |
assets held for rent | 5,690,000 | 6,103,000 | 10,822,000 | 11,094,000 | 6,904,000 | 7,713,000 | 7,209,000 | 9,417,000 | 9,005,000 | 9,064,000 | 9,357,000 | 9,083,000 | 9,823,000 | 9,809,000 | 10,086,000 | 8,492,000 | 6,503,000 | 4,705,000 | 5,131,000 | 4,958,000 | 4,875,000 | 3,922,000 | 2,976,000 | |||||||||||||||||||||||||||||||||||||||||||||
property and equipment | 6,605,000 | 6,084,000 | 17,709,000 | 17,256,000 | 21,042,000 | 21,077,000 | 20,998,000 | 25,565,000 | 26,100,000 | 23,638,000 | 21,737,000 | 19,117,000 | 18,259,000 | 17,657,000 | 17,462,000 | 16,450,000 | 11,231,000 | 10,120,000 | 5,300,000 | 5,347,000 | 5,407,000 | 5,572,000 | ||||||||||||||||||||||||||||||||||||||||||||||
operating lease right-of-use assets | 10,128,000 | 10,674,000 | 14,402,000 | 10,400,000 | 10,779,000 | 11,446,000 | 12,651,000 | 14,935,000 | 15,592,000 | 15,292,000 | 15,832,000 | 17,306,000 | 18,161,000 | 18,705,000 | 17,157,000 | 17,400,000 | 10,524,000 | 9,675,000 | 585,000 | 740,000 | 892,000 | 1,040,000 | 1,177,000 | 1,079,000 | 1,196,000 | |||||||||||||||||||||||||||||||||||||||||||
long-term deposits and other assets | 378,000 | 379,000 | 271,000 | 241,000 | 245,000 | 273,000 | 316,000 | 316,000 | 284,000 | 281,000 | 256,000 | 323,000 | 265,000 | 325,000 | 386,000 | 452,000 | 356,000 | 230,000 | 35,000 | 36,000 | 36,000 | 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||
available-for-sale securities, long-term | 19,055,000 | 4,884,000 | 2,688,000 | 822,000 | 1,156,000 | 1,839,000 | 2,019,000 | 490,000 | 489,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity investments | 995,000 | 995,000 | 995,000 | 995,000 | 5,069,000 | 5,069,000 | 5,069,000 | 5,069,000 | 5,069,000 | 5,069,000 | 5,069,000 | 4,372,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets | 8,857,000 | 9,559,000 | 18,415,000 | 19,325,000 | 20,235,000 | 21,149,000 | 22,064,000 | 29,177,000 | 30,629,000 | 32,088,000 | 74,013,000 | 76,524,000 | 149,286,000 | 152,149,000 | 155,011,000 | 148,714,000 | 30,116,000 | 31,049,000 | 19,882,000 | 20,588,000 | 21,294,000 | 21,982,000 | 16,485,000 | 4,446,000 | ||||||||||||||||||||||||||||||||||||||||||||
goodwill | 212,304,000 | 212,304,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 224,741,000 | 223,936,000 | 195,664,000 | 58,449,000 | 58,449,000 | 33,506,000 | 33,506,000 | 33,506,000 | 33,637,000 | 28,351,000 | 9,524,000 | ||||||||||||||||||||||||||||||||||||||||||||
total assets | 395,141,000 | 399,487,000 | 381,652,000 | 374,976,000 | 401,602,000 | 412,714,000 | 411,152,000 | 433,177,000 | 446,470,000 | 450,229,000 | 487,679,000 | 470,379,000 | 544,012,000 | 554,057,000 | 559,391,000 | 520,969,000 | 240,024,000 | 234,829,000 | 195,887,000 | 113,970,000 | 94,987,000 | 92,816,000 | 84,228,000 | 51,742,000 | 48,073,000 | 45,467,000 | 46,448,976 | 21,787,020 | 12,293,079 | 12,143,203 | 8,881,486 | 8,481,722 | 8,598,774 | 7,926,614 | 10,766,378 | 10,550,454 | 10,775,853 | 12,369,622 | 13,225,577 | 13,870,187 | 15,160,420 | 16,072,918 | 14,254,063 | 14,806,565 | 15,981,534 | 3,353,342 | 3,207,024 | 3,437,081 | 3,419,277 | 3,169,829 | 3,417,833 | 3,068,907 | 1,869,170 | 1,662,017 | 1,564,376 | 1,471,981 | 1,386,251 | 1,309,059 | 1,293,655 | 1,384,760 | 1,328,018 | 1,333,958 | 1,310,008 | 1,203,450 | 1,745,300 | 1,302,592 | 850,725 | 854,527 |
liabilities and shareholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 3,297,000 | 3,573,000 | 3,838,000 | 4,213,000 | 4,984,000 | 6,940,000 | 11,980,000 | 10,686,000 | 15,525,000 | 15,367,000 | 13,140,000 | 11,537,000 | 11,711,000 | 14,945,000 | 14,296,000 | 9,847,000 | 4,276,000 | 3,672,000 | 2,355,000 | 3,077,000 | 3,522,000 | 3,119,000 | 1,570,000 | 876,000 | 1,264,000 | 720,000 | 1,089,553 | 842,941 | 586,334 | 690,702 | 420,387 | 531,919 | 638,014 | 710,719 | 1,085,723 | 864,452 | 772,870 | 1,029,373 | 978,279 | 640,271 | 900,348 | 474,662 | 168,838 | 170,106 | 707,983 | 867,070 | 840,498 | 1,041,717 | 1,053,911 | 862,492 | 1,064,283 | 531,616 | 534,001 | 403,103 | 310,442 | 347,063 | 276,515 | 117,068 | 228,898 | 343,280 | 268,227 | 192,834 | 211,825 | 400,277 | 586,150 | 654,625 | 362,567 | 284,014 |
accrued expenses and other current liabilities | 8,213,000 | 12,451,000 | 8,449,000 | 8,128,000 | 8,863,000 | 11,932,000 | 8,568,000 | 10,114,000 | 10,701,000 | 9,782,000 | 7,778,000 | 7,187,000 | 6,966,000 | 7,142,000 | 12,057,000 | 9,911,000 | 8,146,000 | 5,369,000 | 3,364,000 | 2,606,000 | 3,080,000 | 3,369,000 | 642,000 | 204,000 | 142,000 | 91,000 | 162,981 | 172,879 | 202,779 | 200,548 | 170,419 | 63,619 | 69,327 | 116,399 | 50,614 | 80,037 | 113,340 | 146,438 | 150,980 | 62,741 | 160,898 | 121,869 | 90,475 | 10,440 | 30,044 | 146,626 | 52,532 | 51,820 | 19,981 | 8,495 | 149,609 | 126,224 | 58,207 | 69,582 | 81,420 | 108,015 | ||||||||||||
sales taxes payable | 3,929,000 | 4,256,000 | 4,351,000 | 4,860,000 | 5,395,000 | 5,442,000 | 5,469,000 | 4,989,000 | 4,585,000 | 4,151,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
lease liabilities, operating, current portion | 1,835,000 | 1,511,000 | 2,788,000 | 2,504,000 | 2,645,000 | 2,797,000 | 2,906,000 | 2,915,000 | 2,906,000 | 2,860,000 | 2,769,000 | 2,733,000 | 2,795,000 | 2,758,000 | 2,648,000 | 2,223,000 | 1,455,000 | 1,107,000 | 729,000 | 844,000 | 826,000 | 804,000 | ||||||||||||||||||||||||||||||||||||||||||||||
debt, current portion | 10,449,000 | 10,943,000 | 12,231,000 | 10,614,000 | 8,619,000 | 6,833,000 | 5,034,000 | 1,935,000 | 1,250,000 | 1,814,000 | 2,067,000 | 1,363,000 | 557,000 | 862,000 | 1,771,000 | 2,924,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities | 27,723,000 | 32,734,000 | 32,166,000 | 30,819,000 | 38,658,000 | 42,178,000 | 42,622,000 | 39,587,000 | 47,319,000 | 44,582,000 | 36,948,000 | 33,298,000 | 35,040,000 | 40,381,000 | 35,793,000 | 31,275,000 | 16,381,000 | 15,573,000 | 8,362,000 | 7,490,000 | 25,460,000 | 7,669,000 | 4,944,000 | 3,093,000 | 2,701,000 | 1,939,000 | 2,095,365 | 1,663,728 | 1,311,577 | 1,512,898 | 1,089,343 | 1,045,091 | 1,085,580 | 1,133,163 | 3,464,488 | 2,263,541 | 1,479,984 | 1,725,793 | 1,631,901 | 1,160,156 | 1,464,385 | 1,261,776 | 833,014 | 613,004 | 1,063,655 | 1,628,140 | 1,228,905 | 1,423,192 | 1,473,479 | 1,365,338 | 1,468,094 | 1,021,142 | 687,813 | 579,248 | 516,148 | 502,774 | 463,845 | 340,702 | 10,377,601 | 10,062,273 | 9,506,001 | 356,673 | 8,654,441 | 8,098,243 | 7,658,186 | 1,030,087 | 507,517 | 441,305 |
lease liabilities, operating, long-term | 12,165,000 | 12,723,000 | 15,189,000 | 11,075,000 | 12,579,000 | 13,205,000 | 13,677,000 | 14,388,000 | 15,114,000 | 14,962,000 | 14,474,000 | 15,205,000 | 15,917,000 | 16,466,000 | 15,047,000 | 15,474,000 | 9,299,000 | 8,757,000 | 26,000 | 116,000 | 332,000 | 550,000 | ||||||||||||||||||||||||||||||||||||||||||||||
debt, long-term | 2,499,000 | 4,997,000 | 7,823,000 | 10,451,000 | 15,681,000 | 18,311,000 | 20,937,000 | 23,572,000 | 23,692,000 | 23,793,000 | 24,207,000 | 6,188,000 | 6,313,000 | 6,353,000 | 6,122,000 | 5,019,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax liabilities | 130,000 | 124,000 | 100,000 | 193,000 | 193,000 | 188,000 | 286,000 | 263,000 | 263,000 | 250,000 | 389,000 | 1,149,000 | 4,888,000 | 5,487,000 | 7,269,000 | 10,973,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities | 42,517,000 | 50,578,000 | 56,191,000 | 53,534,000 | 68,197,000 | 75,051,000 | 79,135,000 | 81,049,000 | 88,363,000 | 86,041,000 | 79,430,000 | 58,066,000 | 65,492,000 | 73,920,000 | 70,132,000 | 68,688,000 | 31,247,000 | 29,583,000 | 9,036,000 | 8,127,000 | 27,278,000 | 49,362,000 | 7,266,000 | 5,476,000 | 3,707,000 | 2,319,000 | 2,519,333 | 2,131,920 | 1,821,615 | 2,050,617 | 1,666,943 | 1,660,764 | 5,795,088 | 4,760,474 | 4,178,239 | 3,004,429 | 2,246,028 | 2,510,251 | 2,441,176 | 1,993,132 | 2,312,426 | 2,136,601 | 1,586,856 | 1,408,149 | 1,904,385 | 16,624,863 | 16,066,394 | 16,099,775 | 15,819,636 | 15,655,852 | 15,453,615 | 14,809,595 | 13,299,845 | 12,842,503 | 12,385,875 | 11,955,824 | 11,486,656 | 10,857,971 | 10,511,768 | 10,201,440 | 9,650,168 | 9,160,940 | 8,808,608 | 8,165,743 | 7,728,186 | 5,686,992 | 4,589,043 | 3,944,049 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of march 31, 2025 and december 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock | 48,000 | 46,000 | 45,000 | 44,000 | 43,000 | 43,000 | 43,000 | 43,000 | 43,000 | 42,000 | 42,000 | 41,000 | 41,000 | 34,000 | 33,000 | 32,000 | 26,000 | 21,000 | 21,000 | 20,000 | 19,000 | 19,000 | 19,000 | 18,237 | 16,107 | 14,145 | 14,021 | 13,333 | 13,210 | 13,017 | 12,864 | 12,769 | 12,607 | 12,508 | 12,447 | 12,172 | 12,154 | 12,107 | 12,084 | 12,053 | 12,027 | 11,941 | 5,030 | 70,415 | 70,036 | 70,036 | 69,680 | 69,680 | 69,680 | 69,680 | 69,680 | 69,680 | 69,680 | 69,680 | 69,640 | 69,640 | 69,640 | 69,640 | ||||||||||
additional paid-in capital | 688,092,000 | 659,063,000 | 651,305,000 | 632,593,000 | 623,412,000 | 619,227,000 | 611,739,000 | 604,060,000 | 597,810,000 | 591,002,000 | 585,397,000 | 579,929,000 | 542,864,000 | 307,246,000 | 302,598,000 | 282,076,000 | 199,941,000 | 145,432,000 | 143,485,000 | 137,392,000 | 116,013,000 | 114,951,000 | 114,160,000 | 115,775,040 | 92,653,721 | 84,517,966 | 84,036,444 | 80,494,953 | 79,676,523 | 74,891,236 | 74,355,645 | 74,027,593 | 73,719,666 | 72,983,853 | 72,823,398 | 72,347,856 | 72,149,598 | 71,969,748 | 71,911,328 | 71,862,179 | 71,727,860 | 71,519,816 | 43,618,686 | 43,480,884 | 43,368,029 | 43,347,858 | 43,255,374 | 43,194,027 | 43,136,893 | 42,948,013 | 42,901,325 | 42,849,142 | 42,708,130 | 42,654,888 | 42,576,260 | 42,436,420 | 42,393,781 | 42,351,167 | 42,314,560 | 42,287,747 | 42,261,432 | 42,229,912 | 42,184,559 | 42,167,816 | 42,154,117 | |||
accumulated other comprehensive loss, net of taxes | 33,000 | -566,000 | -345,000 | -660,000 | -499,000 | -534,000 | -679,000 | -1,257,000 | -900,000 | -438,000 | -282,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -335,549,000 | -325,138,000 | -313,342,000 | -299,960,000 | -270,828,000 | -260,629,000 | -246,915,000 | -194,597,000 | -184,640,000 | -112,086,000 | -105,020,000 | -90,548,000 | -90,627,000 | -98,503,000 | -97,385,000 | -95,257,000 | -94,124,000 | -77,744,000 | -100,052,000 | -60,450,000 | -69,766,000 | -70,604,000 | -71,031,000 | -71,863,637 | -73,014,731 | -74,060,651 | -73,957,883 | -73,293,747 | -72,868,779 | -72,100,567 | -71,202,369 | -67,878,835 | -66,909,834 | -65,553,751 | -64,326,923 | -63,207,536 | -62,138,848 | -61,144,469 | -60,112,987 | -59,200,419 | -58,337,964 | -57,454,608 | -56,895,237 | -56,100,759 | -55,818,253 | -55,811,077 | -55,299,489 | -54,947,261 | -54,448,368 | -54,151,491 | -53,740,321 | -53,261,653 | -52,824,973 | -52,194,852 | -51,724,213 | -51,280,141 | -50,742,997 | -50,211,222 | -49,855,987 | -49,293,365 | -48,282,438 | -46,638,599 | -45,975,774 | -45,313,279 | ||||
total shareholders’ equity | 352,624,000 | 333,405,000 | 337,663,000 | 332,017,000 | 352,128,000 | 358,107,000 | 364,188,000 | 408,249,000 | 412,313,000 | 478,520,000 | 480,137,000 | 489,259,000 | 452,281,000 | 208,777,000 | 205,246,000 | 186,851,000 | 105,843,000 | 67,709,000 | 43,454,000 | 76,962,000 | 46,266,000 | 44,366,000 | 43,148,000 | 43,929,643 | 19,655,100 | 10,471,464 | 7,214,543 | 6,820,958 | 2,803,686 | 7,546,025 | 8,529,825 | |||||||||||||||||||||||||||||||||||||
total liabilities and shareholders’ equity | 395,141,000 | 401,602,000 | 412,714,000 | 411,152,000 | 433,177,000 | 446,470,000 | 450,229,000 | 487,679,000 | 470,379,000 | 544,012,000 | 554,057,000 | 559,391,000 | 520,969,000 | 240,024,000 | 234,829,000 | 195,887,000 | 113,970,000 | 94,987,000 | 92,816,000 | 84,228,000 | 51,742,000 | 48,073,000 | 45,467,000 | 46,448,976 | 21,787,020 | 12,293,079 | 12,143,203 | 8,881,486 | 8,481,722 | 8,598,774 | 10,550,454 | 10,775,853 | ||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 153 and 1,603 as of december 31, 2024 and december 31, 2023, respectively | 9,168,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets, discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
available-for-sale securities, long term | 4,628,000 | 548,000 | 1,332,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term assets, discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities, discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term liabilities, discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of december 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 184,000 | 31,000 | 31,000 | 31,000 | 31,000 | 31,000 | 31,000 | 31,000 | 31,000 | 28,000 | 10,000 | 10,000 | 53,000 | 53,000 | 53,000 | 53,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 955 and 1,707 as of september 30, 2024 and december 31, 2023, respectively | 17,918,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
financing lease right-of-use assets | 30,000 | 36,000 | 65,000 | 94,000 | 124,000 | 1,807,000 | 242,000 | 272,000 | 310,000 | 367,000 | 404,000 | 440,000 | 476,000 | 511,000 | 430,000 | 17,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
warranty liability | 186,000 | 183,000 | 7,800,000 | 7,858,000 | 8,215,000 | 8,436,000 | 8,895,000 | 8,312,000 | 8,367,000 | 8,722,000 | 9,176,000 | 9,398,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
lease liabilities, financing, current portion | 323,000 | 317,000 | 352,000 | 376,000 | 398,000 | 426,000 | 161,000 | 158,000 | 156,000 | 153,000 | 151,000 | 149,000 | 146,000 | 144,000 | 114,000 | 8,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
lease liabilities, financing, long-term | 913,000 | 996,000 | 1,086,000 | 1,169,000 | 1,250,000 | 1,330,000 | 95,000 | 126,000 | 166,000 | 213,000 | 253,000 | 291,000 | 329,000 | 367,000 | 316,000 | 12,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of september 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 1,061 and 1,710 as of june 30, 2024 and december 31, 2023, respectively | 18,064,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of june 30, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 1,745 and 1,710 as of march 31, 2024 and december 31, 2023, respectively | 18,574,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of march 31, 2024 and december 31, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 1,710 and 739 as of december 31, 2023 and december 31, 2022, respectively | 18,657,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration, current portion | 52,000 | 86,000 | 3,296,000 | 2,138,000 | 2,671,000 | 1,603,000 | 3,684,000 | 5,127,000 | 2,714,000 | 2,854,000 | 2,390,000 | 2,637,000 | 365,000 | 377,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration, long-term | 363,000 | 1,909,000 | 1,880,000 | 2,318,000 | 3,191,000 | 1,912,000 | 3,008,000 | 4,900,000 | 5,524,000 | 5,524,000 | 4,271,000 | 4,515,000 | 386,000 | 388,000 | 1,486,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 10,000 | 55,000 | 101,000 | 73,000 | 42,000 | 48,000 | 56,000 | 980,000 | 726,000 | 262,000 | 133,000 | 4,000 | 3,000 | 7,000 | 13,000 | 31,000 | 37,855 | 45,364 | 52,520 | 45,512 | 51,235 | 56,141 | ||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of december 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for credit losses of 1,244 and 739 as of september 30, 2023 and december 31, 2022, respectively | 24,556,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of september 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,265 and 739 as of june 30, 2023 and december 31, 2022, respectively | 26,860,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of june 30, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 956 and 739 as of march 31, 2023 and december 31, 2022, respectively | 30,343,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of march 31, 2023 and december 31, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 739 and 275 as of december 31, 2022 and december 31, 2021, respectively | 33,936,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of december 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 496 and 275 as of september 30, 2022 and december 31, 2021, respectively | 32,436,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of september 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 458 and 275 as of june 30, 2022 and december 31, 2021, respectively | 31,257,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of june 30, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 275 and 275 as of march 31, 2022 and december 31, 2021, respectively | 24,271,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments | 4,372,000 | 4,372,000 | 4,372,000 | 5,872,000 | 5,872,000 | 5,872,000 | 3,610,000 | 2,500,000 | 2,500,000 | 2,500,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of march 31, 2022 and december 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 275 and 85 as of december 31, 2021 and december 31, 2020, respectively | 23,217,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
warrant liability | 17,667,000 | 39,602,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of december 31, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 287 and 85 as of september 30, 2021 and december 31, 2020, respectively | 20,232,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit | 2,161,000 | 3,372,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
warrant liability, current portion | 2,780,000 | 1,914,000 | 963,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of september 30, 2021 and december 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -163,000 | -451 | -601 | -1,390 | -949 | -6,448 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 107 and 85 as of june 30, 2021 and december 31, 2020, respectively | 21,093,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | 3,000 | -3,507 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 80 and 85 at march 31, 2021 and december 31, 2020, respectively | 10,669,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at march 31, 2021and december 31, 2020, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 85 and 68 at december 31, 2020 and 2019, respectively | 8,006,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
warrant liability, long-term | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at december 31, 2020 and 2019, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash in escrow | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade | 6,095,000 | 4,351,000 | 8,205,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest receivable | 54,000 | 41,000 | 27,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 68 and 0 at december 31, 2019 and 2018, respectively | 5,345,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity method investment in savsu | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration, long term | 1,537,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 shares issued and outstanding at december 31, 2019 and 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 68 and 0 at september 30, 2019 and december 31, 2018, respectively | 4,313,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
leasehold improvements | 1,599,000 | 1,284,000 | 1,284,000 | 1,284,000 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,284,491 | 1,121,362 | 1,121,362 | 1,121,362 | 1,121,362 | 1,121,362 | 1,121,362 | 941,925 | 919,035 | 943,878 | 864,361 | 3,936 | 202,270 | 202,270 | 202,270 | ||||||||||||||||||||||||||||||||||
furniture and computer equipment | 588,000 | 577,000 | 704,000 | 706,000 | 705,948 | 693,399 | 692,270 | 682,466 | 681,096 | 681,096 | 667,213 | 650,912 | 677,734 | 652,941 | 584,603 | 557,666 | 535,768 | 514,056 | 500,313 | 476,788 | 325,691 | 334,159 | 309,626 | 300,581 | 300,143 | 296,832 | 294,930 | 288,725 | 286,280 | 245,503 | 187,147 | 177,013 | 174,166 | 174,166 | 172,906 | 170,256 | 166,243 | 166,243 | 163,123 | 164,964 | 164,964 | 164,748 | 120,693 | 105,418 | 96,462 | 85,387 | ||||||||||||||||||||||
manufacturing and other equipment | 2,247,000 | 1,733,000 | 1,803,000 | 1,657,000 | 1,510,729 | 1,229,318 | 1,194,659 | 1,148,006 | 1,075,049 | 1,061,791 | 943,071 | 922,220 | 922,647 | 1,029,600 | 1,025,521 | 1,025,521 | 1,017,262 | 1,007,127 | 989,989 | 972,386 | 944,089 | 828,379 | 773,990 | 764,258 | 763,135 | 757,060 | 746,613 | 741,771 | 739,516 | 708,382 | 655,098 | 623,782 | 592,941 | 582,136 | 553,600 | 542,775 | 534,828 | 531,874 | 530,649 | 319,224 | 319,224 | 319,224 | 256,069 | 210,558 | 183,887 | 177,827 | ||||||||||||||||||||||
subtotal | 4,434,000 | 3,594,000 | 3,791,000 | 3,647,000 | 3,501,168 | 3,207,208 | 3,171,420 | 3,114,963 | 3,040,636 | 3,027,378 | 2,894,775 | 2,857,623 | 2,884,872 | 2,967,032 | 2,894,615 | 2,867,678 | 2,837,521 | 2,805,674 | 2,774,793 | 2,733,665 | 2,391,142 | 2,283,900 | 2,204,978 | 2,186,201 | 2,184,640 | 2,175,254 | 1,983,468 | 1,949,531 | 1,969,674 | 1,818,246 | 846,181 | 800,795 | 767,107 | 756,302 | 726,506 | 713,031 | 701,071 | 698,117 | 693,772 | 686,458 | 686,458 | 686,242 | 579,032 | 315,976 | 280,349 | 263,214 | ||||||||||||||||||||||
less: accumulated depreciation | -2,298,000 | -2,276,000 | -2,424,000 | -2,328,000 | -2,234,286 | -2,163,430 | -2,084,769 | -2,008,927 | -1,930,140 | -1,846,496 | -1,759,794 | -1,670,245 | -1,585,914 | -1,605,173 | -1,513,071 | -1,421,279 | -1,333,608 | -1,246,787 | -1,161,706 | -1,078,060 | -1,006,048 | -984,882 | -924,663 | -862,157 | -733,347 | -673,782 | -615,085 | -555,459 | -501,767 | -472,780 | -447,393 | -375,203 | -352,331 | |||||||||||||||||||||||||||||||||||
net property and equipment | 2,136,000 | 1,318,000 | 1,367,000 | 1,319,000 | 1,266,882 | 1,043,778 | 1,086,651 | 1,106,036 | 1,110,496 | 1,180,882 | 1,134,981 | 1,187,378 | 1,298,958 | 1,361,859 | 1,381,544 | 1,446,399 | 1,503,913 | 1,558,887 | 1,613,087 | 1,655,605 | 1,385,094 | 1,299,018 | 1,280,315 | 1,324,044 | 1,386,305 | 1,441,907 | 1,309,686 | 1,334,446 | 1,414,215 | 1,316,479 | 373,401 | 353,402 | 344,003 | 357,778 | 351,303 | 360,700 | 370,846 | 389,774 | 408,512 | 405,422 | 432,234 | 457,804 | 379,244 | 134,394 | 105,817 | 111,479 | ||||||||||||||||||||||
long-term deposits | 36,000 | 136,000 | 36,000 | 36,000 | 36,166 | 36,166 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued compensation | 1,576,000 | 963,000 | 630,000 | 998,000 | 712,615 | 517,692 | 392,248 | 491,432 | 368,321 | 286,063 | 248,023 | 175,829 | 408,004 | 523,694 | 463,558 | 419,766 | 372,426 | 326,928 | 272,923 | 535,029 | 373,417 | 314,957 | 208,127 | 503,194 | 224,625 | 218,405 | 288,337 | 363,101 | 136,322 | 97,351 | 75,605 | 86,563 | 85,261 | 87,689 | 85,910 | 95,619 | 102,108 | 103,987 | 105,671 | 92,588 | ||||||||||||||||||||||||||||
lease liability - operating, current portion | 771,000 | 665,000 | 651,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
lease liability – financing, current portion | 14,000 | 14,000 | 14,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred rent, current portion | 130,000 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration - current | 371,000 | 371,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred rent, long-term | 349,000 | 386,113 | 422,828 | 457,518 | 492,207 | 526,365 | 559,532 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term lease liability - operating | 753,000 | 806,000 | 980,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term lease liability - financing | 6,000 | 10,000 | 13,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration – long-term | 1,560,000 | 1,560,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 26 and 0 at june 30, 2019 and december 31, 2018, respectively | 3,832,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in savsu | 6,100,000 | 6,317,000 | 6,548,000 | 6,856,980 | 1,899,669 | 926,364 | 1,070,120 | 1,367,792 | 1,585,527 | 1,845,632 | 2,075,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at march 31, 2019 and december 31, 2018 | 2,927,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 and 6 at december 31, 2018 and 2017, respectively | 3,045,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 0 and 4,250 shares issued and outstanding at december 31, 2018 and 2017, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 and 5,575 at september 30, 2018 and december 31, 2017, respectively | 2,699,342 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long term deposits | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | 36,166 | |||||||||||||||||||||||||||||||
deferred rent | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 130,216 | 110,284 | 117,501 | 117,501 | 111,250 | 111,250 | 111,250 | 111,250 | 111,250 | 97,880 | 87,234 | |||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 3,187 and 4,250 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 and 5,575 at june 30, 2018 and december 31, 2017, respectively | 2,166,415 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 3,187 and 4,250 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 5,575 at march 31, 2018 and december 31, 2017 | 1,043,815 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 4,250 shares issued and outstanding at march 31, 2018 and december 31, 2017 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 5,575 and 0 at december 31, 2017 and 2016, respectively | 1,021,315 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
promissory note payable to related party, net of discount of 155,996 at december 31, 2016 | 2,844,004 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest, related party | 33,274 | 181,190 | 97,857 | 39,524 | 8,333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 4,250 and 0 shares issued and outstanding at december 31, 2017 and 2016, respectively | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total biolife solutions, inc. shareholders’ equity | 10,092,586 | 6,822,439 | 7,442,610 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 6,575 and 0 at september 30, 2017 and december 31, 2016, respectively | 1,355,115 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 4,250 and 0 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 8,913 and 0 at june 30, 2017 and december 31, 2016, respectively | 1,173,036 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value; 1,000,000 shares authorized, series a, 4,250 shares designated, and 4,250 and 0 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 15,798 and 0 at march 31, 2017 and december 31, 2016 | 1,060,773 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
promissory note payable to related party, net of discount of 62,398 and 155,996 at march 31, 2017 and december 31, 2016 | 3,937,602 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred rent, long term | 590,716 | 685,450 | 713,751 | 740,888 | 766,044 | 784,458 | 809,275 | 832,976 | 848,041 | 874,825 | 753,842 | 795,145 | 840,730 | 891,986 | 918,307 | 942,955 | 798,084 | 838,829 | 714,391 | 697,878 | ||||||||||||||||||||||||||||||||||||||||||||||||
short term investments | 1,651,341 | 2,902,105 | 2,956,428 | 5,606,453 | 7,399,636 | 7,744,285 | 6,012,309 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at december 31, 2016 and 2015 | 1,193,646 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
internal use software | 2,250,638 | 2,021,489 | 1,836,220 | 1,698,735 | 1,187,022 | 762,860 | 334,640 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible asset | 2,215,385 | 2,215,385 | 2,215,385 | 2,215,385 | 2,215,385 | 2,215,385 | 2,215,385 | 2,215,385 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total biolife solutions, inc. shareholders' equity | 3,166,140 | 6,161,527 | 8,508,471 | 9,151,891 | 10,021,514 | 10,836,437 | 11,803,977 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total non-controlling interest equity | 426,612 | 723,586 | 1,087,215 | 1,350,900 | 1,632,510 | 1,855,541 | 2,011,557 | 2,132,340 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders' equity | 3,166,140 | 6,588,139 | 9,859,371 | 10,784,401 | 11,877,055 | 12,847,994 | 13,936,317 | 12,667,207 | 13,398,416 | 14,077,149 | -13,271,521 | -12,662,694 | -12,400,359 | -12,486,023 | -12,035,782 | -11,740,688 | -11,430,675 | -11,180,486 | -10,100,405 | -9,548,912 | -7,826,982 | |||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders' equity | 7,926,614 | 10,766,378 | 12,369,622 | 13,225,577 | 13,870,187 | 15,160,420 | 16,072,918 | 14,254,063 | 14,806,565 | 15,981,534 | 3,353,342 | 3,207,024 | 3,437,081 | 3,419,277 | 3,169,829 | 3,417,833 | 3,068,907 | 1,869,170 | 1,662,017 | 1,386,251 | 1,309,059 | 1,333,958 | ||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at september 30, 2016 and december 31, 2015 | 1,311,006 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
note payable, related party, net of discount of 249,593 at september 30, 2016 | 1,750,407 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at june 30, 2016 and december 31, 2015 | 1,284,015 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
note payable, related party, net of discount of 343,191 at june 30, 2016 | 656,809 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at march 31, 2016 and december 31, 2015 | 1,190,260 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long term liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at december 31, 2015 and 2014 | 929,289 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at september 30, 2015 and december 31, 2014 | 792,274 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at june 30, 2015 and december 31, 2014 | 809,387 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at march 31, 2015 and december 31, 2014 | 851,044 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 0 at december 31, 2014 and 1,100 at december 31, 2013 | 901,623 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred financing costs | 114,874 | 129,136 | 143,399 | 157,506 | 171,458 | 189,855 | 208,251 | 84,997 | 112,042 | 139,384 | 70,466 | 81,896 | 97,220 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
promissory notes payable, related parties | 10,603,127 | 10,603,127 | 10,603,127 | 10,603,127 | 10,603,127 | 10,603,127 | 10,603,127 | 10,303,127 | 10,128,127 | 9,903,127 | 9,653,127 | 9,383,127 | 9,033,127 | 8,738,127 | 8,488,127 | 8,138,127 | 7,888,127 | 7,588,127 | 6,963,127 | 6,463,127 | 4,463,127 | 3,963,127 | 3,463,127 | |||||||||||||||||||||||||||||||||||||||||||||
accrued interest, related parties | 3,501,610 | 3,316,055 | 3,130,501 | 2,944,946 | 2,759,391 | 2,573,836 | 2,388,281 | 2,204,738 | 2,025,961 | 1,852,433 | 1,680,756 | 1,515,517 | 1,354,975 | 1,199,601 | 1,049,038 | 903,346 | 766,973 | 632,372 | 504,080 | 385,814 | 193,778 | |||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at september 30, 2014 and december 31, 2013 | 775,076 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | 90,000 | 20,000 | 20,000 | 178,717 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 25,833 | 8,334 | 19,166 | 109,583 | 7,083 | |||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive | -6,606 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at june 30, 2014 and december 31, 2013 | 566,540 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at march 31, 2014 and december 31, 2013 | 1,325,564 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at december 31, 2013 and 2012 | 1,009,316 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue, long term | 89,167 | 94,167 | 99,167 | 104,167 | 109,167 | 114,167 | 119,167 | 124,167 | 129,167 | 134,167 | 139,167 | 144,167 | 149,167 | 154,167 | 67,500 | 70,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at september 30, 2013 and december 31, 2012 | 1,026,858 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at june 30, 2013 and december 31, 2012 | 980,974 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at march 31, 2013 and december 31, 2012 | 976,157 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at december 31, 2012 and 2011 | 600,153 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at september 30, 2012 and december 31, 2011 | 797,943 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at june 30, 2012 and december 31, 2011 | 359,190 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at march 31, 2012 and december 31, 2011 | 471,816 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at december 31, 2011 and 2010 | 547,143 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at both september 30, 2011 and december 31, 2010 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: accumulated depreciation and amortization | -423,104 | -398,524 | -330,225 | -308,343 | -285,260 | -281,036 | -254,224 | -228,438 | -199,788 | -181,582 | -174,532 | -151,735 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses | 100,445 | 48,022 | 88,867 | 57,841 | 70,630 | 51,251 | 196,284 | 222,425 | 203,929 | 265,879 | 144,950 | 150,208 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders' equity | -10,821,499 | -10,483,843 | -9,218,113 | -8,816,680 | -8,322,150 | -7,498,600 | -6,962,293 | -5,982,886 | -4,384,400 | -3,738,318 | -3,089,522 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders' equity | 1,564,376 | 1,471,981 | 1,293,655 | 1,384,760 | 1,328,018 | 1,310,008 | 1,203,450 | 1,745,300 | 1,302,592 | 850,725 | 854,527 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 1,100 at june 30, 2011 and december 31, 2010, respectively | 395,324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized, 69,679,854 issued and outstanding at june 30, 2011 and december 31, 2010 | 69,680 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 at march 31, 2011 and december 31, 2010, respectively | 356,701 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 1,100 and 550 at december 31, 2010 and 2009, respectively | 338,899 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 7,400 and 550 at september 30, 2010 and december 31, 2009, respectively | 317,058 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized, 69,679,854 issued and outstanding | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
at september 30, 2010 and december 31, 2009 | 69,680 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 39,900 and 550 at june 30, 2010 and december 31, 2009, respectively | 285,241 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized, 69,679,854 issued and outstanding at june 30, 2010 and december 31, 2009 | 69,680 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 20,600 and 550 at march 31, 2010 and december 31, 2009, respectively | 358,772 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
authorized, 69,679,854 issued and outstanding at march 31, 2010 and december 31, 2009 | 69,680 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 550 and 29,000 at december 31, 2009 and 2008, respectively | 315,365 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 5,000 and 29,000 at september 30, 2009 and december 31, 2008, respectively | 369,329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 9,000 and 29,000 at june 30, 2009 and december 31, 2008, respectively | 199,192 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 12,000 and 29,000 at march 31, 2009 and december 31, 2008, respectively | 244,963 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other receivable | 79,904 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
modular clean room | 202,270 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 5,000 at both september 30, 2008 and december 31, 2007 | 362,145 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | 133,257 | 292,440 | 285,068 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares authorized, 69,639,854 and 69,606,520 shares issued and outstanding at september 30, 2008 and december 31, 2007, respectively | 69,640 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable, trade, net of allowance for doubtful accounts of 3,000 and 5,000 at june 30, 2008 and december 31, 2007, respectively | 228,931 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current assets | 14,167 | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 3,000 and 5,000 at march 31, 2008 and december 31, 2007, respectively | 214,751 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shares authorized, 69,639,854 and 69,606,520 shares issued and outstanding at march 31, 2008 and december 31, 2007 | 69,640 |
We provide you with 20 years of balance sheets for BioLife Solutions stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BioLife Solutions. Explore the full financial landscape of BioLife Solutions stock with our expertly curated balance sheets.
The information provided in this report about BioLife Solutions stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.